Biochemical and pharmacological control of the multiplicity of coupling at G-protein-coupled receptors

Pharmacology and Therapeutics

Volumn 99, Issue 1, 2003, Pages 25-44

  Hermans, Emmanuel ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Agonist selective trafficking of receptor signalling; Desensitisation; G protein coupled receptors; Intracellular signalling; Promiscuity; Receptor regulation; Specificity

Indexed keywords

ADENOSINE RECEPTOR; ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; CALCITONIN; CALCITONIN RECEPTOR; CHOLECYSTOKININ; CHOLECYSTOKININ RECEPTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; DOPAMINE RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR; G PROTEIN COUPLED RECEPTOR; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR AGONIST; GONADORELIN; GONADOTROPIN RECEPTOR; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; LUTEINIZING HORMONE; LUTEINIZING HORMONE RECEPTOR; MUSCARINIC RECEPTOR; OPIATE RECEPTOR; OXYTOCIN; PARATHYROID HORMONE; PARATHYROID HORMONE RECEPTOR; PROSTAGLANDIN RECEPTOR; SEROTONIN RECEPTOR; SUBSTANCE P RECEPTOR; THYROTROPIN; UNINDEXED DRUG;

AGONIST; ARTICLE; BIOCHEMISTRY; CELL COMPARTMENTALIZATION; CELL TRANSFER; DESENSITIZATION; DIMERIZATION; DRUG EFFECT; DRUG POTENCY; EVIDENCE BASED MEDICINE; HUMAN; INHIBITION KINETICS; NONHUMAN; PALMITOYLATION; PHARMACODYNAMICS; PHOSPHORYLATION; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DENSITY; RNA EDITING; SIGNAL TRANSDUCTION;

EID: 0038540318     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(03)00051-2     Document Type: Article

References (270)

1. s. J Neurochem. 72:1999;2032-2038.
2. 1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration. Nature. 407:2000;94-98.
3. Abel A., Wittau N., Wieland T., Schultz G., Kalkbrenner F. Cell cycle-dependent coupling of the vasopressin V1a receptor to different G proteins. J Biol Chem. 275:2000;32543-32551.
4. i/o activation profiles in CHO cells expressing human muscarinic acetylcholine receptors: dependence on agonist as well as receptor-subtype. Br J Pharmacol. 132:2001;950-958.
5. Albert P.R., Robillard L. G protein specificity: traffic direction required. Cell Signal. 14:2002;407-418.
6. 2C receptors expressed in human embryonic kidney 293 cells. Eur J Pharmacol. 383:1999;311-319.
7. Alberts G.L., Pregenzer J.F., Im W.B. Advantages of heterologous expression of human D2long dopamine receptors in human neuroblastoma SH-SY5Y over human embryonic kidney 293 cells. Br J Pharmacol. 131:2000;514-520.
8. q/11. J Biol Chem. 269:1994;13733-13735.
9. Allgeier A., Laugwitz K.L., Van-Sande J., Schultz G., Dumont J.E. Multiple G-protein coupling of the dog thyrotropin receptor. Mol Cell Endocrinol. 127:1997;81-90.
10. Anand-Srivastava M.B., Palaparti A., Pion J. Differential regulation of G-protein expression by vasoactive peptides. Mol Cell Biochem. 176:1997;21-27.
11. Angers S., Salahpour A., Bouvier M. Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Annu Rev Pharmacol Toxicol. 42:2002;409-435.
12. Arey B.J., Stevis P.E., Deecher D.C., Shen E.S., Frail D.E., Negro-Vilar A., Lopez F.J. Induction of promiscuous G protein coupling of the follicle-stimulating hormone (FSH) receptor: a novel mechanism for transducing pleiotropic actions of FSH isoforms. Mol Endocrinol. 11:1997;517-526.
13. Arora K.K., Krsmanovic L.Z., Mores N., O'Farrell H., Catt K.J. Mediation of cyclic AMP signaling by the first intracellular loop of the gonadotropin-releasing hormone receptor. J Biol Chem. 273:1998;25581-25586.
14. Arvanitakis L., Geras-Raaka E., Gershengorn M.C. Constitutively signaling G-protein-coupled receptors and human disease. Trends Endocrinol Metab. 9:1998;27-31.
15. Bai M., Trivedi S., Kifor O., Quinn S.J., Brown E.M. Intermolecular interactions between dimeric calcium-sensing receptor monomers are important for its normal function. Proc Natl Acad Sci USA. 96:1999;2834-2839.
16. Barr A.J., Brass L.F., Manning D.R. Reconstitution of receptors and GTP-binding regulatory proteins (G proteins) in Sf9 cells. A direct evaluation of selectivity in receptor·G protein coupling. J Biol Chem. 272:1997;2223-2229.
17. 358 in Helix seven. Br J Pharmacol. 135:2002;997-1002.
18. Berg K.A., Maayani S., Goldfarb J., Scaramellini C., Leff P., Clarke W.P. Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus. Mol Pharmacol. 54:1998;94-104.
19. 2C receptor alters agonist-receptor-effector coupling specificity. Br J Pharmacol. 134:2001;386-392.
20. Berrada K., Plesnicher C.L., Luo X., Thibonnier M. Dynamic interaction of human vasopressin/oxytocin receptor subtypes with G protein-coupled receptor kinases and protein kinase C after agonist stimulation. J Biol Chem. 275:2000;27229-27237.
21. ilα fusion protein following stable expression in CHO cells. FEBS Lett. 462:1999;61-65.
22. Biebermann H., Schoneberg T., Schulz A., Krause G., Gruters A., Schultz G., Gudermann T. A conserved tyrosine residue (Y601) in transmembrane domain 5 of the human thyrotropin receptor serves as a molecular switch to determine G-protein coupling. FASEB J. 12:1998;1461-1471.
23. Birnbaumer L. Receptor-to-effector signaling through G proteins: roles for beta gamma dimers as well as alpha subunits. Cell. 71:1992;1069-1072.
24. Blake A.D., Bot G., Freeman J.C., Reisine T. Differential opioid agonist regulation of the mouse μ opioid receptor. J Biol Chem. 272:1997;782-790.
25. Blank J.L., Brattain K.A., Exton J.H. Activation of cytosolic phosphoinositide phospholipase C by G-protein βγ subunits. J Biol Chem. 267:1992;23069-23075.
26. Blanpain C., Wittamer V., Vanderwinden J.M., Boom A., Renneboog B., Lee B., Le Poul E., El Asmar L., Govaerts C., Vassart G., Doms R.W., Parmentier M. Palmitoylation of CCR5 is critical for receptor trafficking and efficient activation of intracellular signaling pathways. J Biol Chem. 276:2001;23795-23804.
27. Blayney L.M., Gapper P.W., Newby A.C. Phospholipase C isoforms in vascular smooth muscle and their regulation by G-proteins. Br J Pharmacol. 118:1996;1003-1011.
28. Bockaert J., Pin J.P. Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J. 18:1999;1723-1729.
29. Bonhaus D.W., Chang L.K., Kwan J., Martin G.R. Dual activation and inhibition of adenylyl cyclase by cannabinoid receptor agonists: evidence for agonist-specific trafficking of intracellular responses. J Pharmacol Exp Ther. 287:1998;884-888.
30. Boyer J.L., Waldo G.L., Harden T.K. βγ-Subunit activation of G-protein-regulated phospholipase C. J Biol Chem. 267:1992;25451-25456.
31. Brady A.E., Limbird L.E. G protein-coupled receptor interacting proteins: emerging roles in localization and signal transduction. Cell Signal. 14:2002;297-309.
32. s. J Pharmacol Exp Ther. 294:2000;539-547.
33. q/11 proteins. Mol Endocrinol. 13:1999;2025-2038.
34. Bunemann M., Hosey M.M. G-protein coupled receptor kinases as modulators of G-protein signalling. J Physiol. 517:1999;1-23.
35. Burford N.T., Wang D.X., Sadee W. G-protein coupling of μ-opioid receptors (OP3): elevated basal signalling activity. Biochem J. 348:2000;531-537.
36. i proteins. Comparisons of their contributions to GTPase activity and signal transduction and analysis of receptor-G protein activation stoichiometry. J Biol Chem. 273:1998;10367-10375.
37. 1 receptor. Eur J Pharmacol. 374:1999;445-455.
38. 2+/calmodulin-stimulated enzyme expressed in discrete regions of rat brain. J Biol Chem. 269:1994;12190-12195.
39. Camps M., Carozzi A., Schnabel P., Scheer A., Parker P.J., Gierschik P. Isozyme-selective stimulation of phospholipase C-beta 2 by G protein beta gamma-subunits. Nature. 360:1992;684-686.
40. 2A-adrenergic receptor to multiple G-proteins. A simple approach for estimating receptor-G-protein coupling efficiency in a transient expression system. J Biol Chem. 269:1994;5730-5734.
41. Chakrabarti S., Prather P.L., Yu L., Law P.Y., Loh H.H. Expression of the mu-opioid receptor in CHO cells: ability of mu-opioid ligands to promote alpha-azidoanilido[32P]GTP labeling of multiple G protein alpha subunits. J Neurochem. 64:1995;2534-2543.
42. Chakraborty M., Chatterjee D., Kellokumpu S., Rasmussen H., Baron R. Cell cycle-dependent coupling of the calcitonin receptor to different G proteins. Science. 251:1991;1078-1082.
43. αi3. J Neurochem. 74:2000;1068-1078.
44. Changeux J.P., Edelstein S.J. Allosteric receptors after 30 years. Neuron. 21:1998;959-980.
45. Choi E.J., Wong S.T., Hinds T.R., Storm D.R. Calcium and muscarinic agonist stimulation of type I adenylylcyclase in whole cells. J Biol Chem. 267:1992;12440-12442.
46. Christopoulos A., Kenakin T. G protein-coupled receptor allosterism and complexing. Pharmacol Rev. 54:2002;323-374.
47. Chuang T.T., Iacovelli L., Sallese M., De-Blasi A. G protein-coupled receptors: heterologous regulation of homologous desensitization and its implications. Trends Pharmacol Sci. 17:1996;416-421.
48. Ciruela F., Escriche M., Burgueno J., Angulo E., Casado V., Soloviev M.M., Canela E.I., Mallol J., Chan W.Y., Lluis C., McIlhinney R.A., Franco R. Metabotropic glutamate 1α and adenosine A1 receptors assemble into functionally interacting complexes. J Biol Chem. 276:2001;18345-18351.
49. 2+-dependent translocation domain with homology to PKC and GAP. Cell. 65:1991;1043-1051.
50. Cohen D.P., Thaw C.N., Varma A., Gershengorn M.C., Nussenzveig D.R. Human calcitonin receptors exhibit agonist-independent (constitutive) signaling activity. Endocrinology. 138:1997;1400-1405.
51. Conchon S., Barrault M.B., Miserey S., Corvol P., Clauser E. The C-terminal third intracellular loop of the rat AT1A angiotensin receptor plays a key role in G protein coupling specificity and transduction of the mitogenic signal. J Biol Chem. 272:1997;25566-25572.
52. 1 receptor: evidence for signaling pathway-dependent changes in agonist potency and relative intrinsic activity. Mol Pharmacol. 58:2000;1075-1084.
53. 2 dopamine receptor/G protein interaction. Evidence for agonist selection of G protein subtype. J Biol Chem. 276:2001;28667-28675.
54. q. Eur J Biochem. 268:2001;5449-5459.
55. Crawford K.W., Frey E.A., Cote T.E. Angiotensin II receptor recognized by DuP753 regulates two distinct guanine nucleotide-binding protein signaling pathways. Mol Pharmacol. 41:1992;154-162.
56. 2C receptors revealed by antibody capture assays: influence of receptor reserve and relationship to agonist-directed trafficking. Mol Pharmacol. 62:2002;578-589.
57. 2-adrenergic receptor to different G proteins by protein kinase A. Nature. 390:1997;88-91.
58. Daeffler L., Landry Y. Inverse agonism at heptahelical receptors: concept, experimental approach and therapeutic potential. Fundam Clin Pharmacol. 14:2000;73-87.
59. 35S]guanosine-5′-O-(3-thio)triphosphate binding mediated by cholinergic muscarinic receptors in membranes from Chinese hamster ovary cells and rat striatum using an anti-G protein scintillation proximity assay. J Pharmacol Exp Ther. 289:1999;946-955.
60. 1 receptor to phospholipase C in transfected CHO cells. Eur J Pharmacol. 355:1998;85-93.
61. q in reconstituted phospholipid vesicles. Biochemistry. 38:1999;3090-3099.
62. Downes G.B., Gautam N. The G protein subunit gene families. Genomics. 62:1999;544-552.
63. i coupling. J Biol Chem. 270:1995;24753-24760.
64. i coupling domains. J Biol Chem. 271:1996;12826-12832.
65. s. J Biol Chem. 267:1992;15795-15801.
66. Eason M.G., Jacinto M.T., Liggett S.B. Contribution of ligand structure to activation of alpha 2-adrenergic receptor subtype coupling to Gs. Mol Pharmacol. 45:1994;696-702.
67. El Far O., Betz H. G-protein-coupled receptors for neurotransmitter amino acids: C-terminal tails, crowded signalosomes. Biochem J. 365:2002;329-336.
68. Esbenshade T.A., Wang X., Williams N.G., Minneman K.P. Inducible expression of alpha 1B-adrenoceptors in DDT1 MF-2 cells: comparison of receptor density and response. Eur J Pharmacol. 289:1995;305-310.
69. Evans P.D., Robb S., Cheek T.R., Reale V., Hannan F.L., Swales L.S., Hall L.M., Midgley J.M. Agonist-specific coupling of G-protein-coupled receptors to second-messenger systems. Prog Brain Res. 1062:1995;59-68.
70. Exton J.H. Regulation of phosphoinositide phospholipases by hormones, neurotransmitters, and other agonists linked to G proteins. Annu Rev Pharmacol Toxicol. 36:1996;481-509.
71. i protein. Cell Signal. 3:1991;547-557.
72. Felder C.C., Jose P.A., Axelrod J. The dopamine-1 agonist, SKF 82526, stimulates phospholipase-C activity independent of adenylate cyclase. J Pharmacol Exp Ther. 248:1989;171-175.
73. Felder C.C., Kanterman R.Y., Ma A.L., Axelrod J. A transfected m1 muscarinic acetylcholine receptor stimulates adenylate cyclase via phosphatidylinositol hydrolysis. J Biol Chem. 264:1989;20356-20362.
74. Ferguson S.S.G. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev. 53:2001;1-24.
75. 1 receptors in stably cotransfected fibroblast cells. J Biol Chem. 273:1998;4718-4724.
76. Fisher S.K. Homologous and heterologous regulation of receptor-stimulated phosphoinositide hydrolysis. Eur J Pharmacol. 288:1995;231-250.
77. Fong C.W., Milligan G. Analysis of agonist function at fusion proteins between the IP prostanoid receptor and cognate, unnatural and chimaeric G-proteins. Biochem J. 342:1999;457-463.
78. Fox M.T., Harriott P., Walker B., Stone S.R. Identification of potential activators of proteinase-activated receptor-2. FEBS Lett. 417:1997;267-269.
79. Francesconi A., Duvoisin R.M. Role of the second and third intracellular loops of metabotropic glutamate receptors in mediating dual signal transduction activation. J Biol Chem. 273:1998;5615-5624.
80. 2-adrenergic receptor in Chinese hamster ovary cells. Evidence for independent pathways of receptor coupling to adenylate cyclase attenuation and activation. J Biol Chem. 264:1989;11754-11761.
81. Fuchs S., Amiel J., Claudel S., Lyonnet S., Corvol P., Pinet F. Functional characterization of three mutations of the endothelin B receptor gene in patients with Hirschsprung's disease: evidence for selective loss of Gi coupling. Mol Med. 7:2001;115-124.
82. Fukunaga K., Ishii S., Asano K., Yokomizo T., Shiomi T., Shimizu T., Yamaguchi K. Single nucleotide polymorphism of human platelet-activating factor receptor impairs G-protein activation. J Biol Chem. 276:2001;43025-43030.
83. Gailly P., Najimi M., Hermans E. Evidence for the dual coupling of the rat neurotensin receptor with pertussis toxin-sensitive and insensitive G-proteins. FEBS Lett. 483:2000;109-113.
84. oα subunits restore the efficacy of opioids, clonidine and neurotensin giving rise to antinociception in G-protein knock-down mice. Neuropharmacology. 38:1999;1861-1873.
85. Gautam N., Downes G.B., Yan K., Kisselev O. The G-protein βγ complex. Cell Signal. 10:1998;447-455.
86. George S.R., Fan T., Xie Z.D., Tse R., Tam V., Varghese G., O'Dowd B.F. Oligomerization of μ- and δ-opioid receptors. Generation of novel functional properties. J Biol Chem. 275:2000;26128-26135.
87. Gether U. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr Rev. 21:2000;90-113.
88. Gilchrist R.L., Ryu K.S., Ji I., Ji T.H. The luteinizing hormone/chorionic gonadotropin receptor has distinct transmembrane conductors for cAMP and inositol phosphate signals. J Biol Chem. 271:1996;19283-19287.
89. i-coupled signal transduction. J Biol Chem. 273:1998;14912-14919.
90. Gilchrist A., Bunemann M., Li A., Hosey M.M., Hamm H.E. A dominant-negative strategy for studying roles of G proteins in vivo. J Biol Chem. 274:1999;6610-6616.
91. 2 receptors. Mol Pharmacol. 56:1999;1362-1369.
92. Grammatopoulos D.K., Randeva H.S., Levine M.A., Kanellopoulou K.A., Hillhouse E.W. Rat cerebral cortex corticotropin-releasing hormone receptors: evidence for receptor coupling to multiple G-proteins. J Neurochem. 76:2001;509-519.
93. il protein subunits promotes high-affinity agonist binding to the neurotensin receptor NTS-1 expressed in Escherichia coli. FEBS Lett. 493:2001;101-105.
94. Gromoll J., Simoni M., Nordhoff V., Behre H.M., De-Geyter C., Nieschlag E. Functional and clinical consequences of mutations in the FSH receptor. Mol Cell Endocrinol. 125:1996;177-182.
95. q/11 proteins. J Biol Chem. 275:2000;9193-9200.
96. i2. Biochemistry. 35:1996;15162-15173.
97. Gudermann T., Kalkbrenner F., Schultz G. Diversity and selectivity of receptor-G protein interaction. Annu Rev Pharmacol Toxicol. 36:1996;429-459.
98. Gudermann T., Schoneberg T., Schultz G. Functional and structural complexity of signal transduction via G-protein-coupled receptors. Annu Rev Neurosci. 20:1997;399-427.
99. Gurwitz D., Haring R., Heldman E., Fraser C.M., Manor D., Fisher A. Discrete activation of transduction pathways associated with acetylcholine m1 receptor by several muscarinic ligands. Eur J Pharmacol. 267:1994;21-31.
100. Hall R.A., Premont R.T., Lefkowitz R.J. Heptahelical receptor signaling: beyond the G protein paradigm. J Cell Biol. 145:1999;927-932.
101. Hamm H.E. The many faces of G protein signaling. J Biol Chem. 273:1998;669-672.
102. B subtypes in a heterologous cell line. Mol Endocrinol. 6:1992;920-926.
103. Hebert T.E., Bouvier M. Structural and functional aspects of G protein-coupled receptor oligomerization. Biochem Cell Biol. 76:1998;1-11.
104. 2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J Biol Chem. 271:1996;16384-16392.
105. Henderson R., Baldwin J.M., Ceska T.A., Zemlin F., Beckmann E., Downing K.H. Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy. J Mol Biol. 213:1990;899-929.
106. Hepler J.R. Emerging roles for RGS proteins in cell signalling. Trends Pharmacol Sci. 20:1999;376-382.
107. Hermans E., Saunders R., Selkirk J.V., Mistry R., Nahorski S.R., Challiss R.A.J. Complex involvement of pertussis toxin-sensitive G proteins in the regulation of type 1α metabotropic glutamate receptor signaling in baby hamster kidney cells. Mol Pharmacol. 58:2000;352-360.
108. Herrero I., Miras P.M., Sanchez-Prieto J. Functional switch from facilitation to inhibition in the control of glutamate release by metabotropic glutamate receptors. J Biol Chem. 273:1998;1951-1958.
109. i proteins in dual coupling of the luteinizing hormone receptor to adenylyl cyclase and phospholipase C. J Biol Chem. 271:1996;16764-16772.
110. Heuss C., Scanziani M., Gahwiler B.H., Gerber U. G-protein-independent signaling mediated by metabotropic glutamate receptors. Nat Neurosci. 2:1999;1070-1077.
111. Hildebrandt J.D. Role of subunit diversity in signaling by heterotrimeric G proteins. Biochem Pharmacol. 54:1997;325-339.
112. 1b. Neuropharmacology. 37:1998;827-837.
113. 2. J Biol Chem. 274:1999;5163-5169.
114. i. Independent mechanisms for elevating intracellular calcium concentrations from intracellular stores. J Biol Chem. 274:1999;28682-28689.
115. Horn F., Weare J., Beukers M.W., Horsch S., Bairoch A., Chen W., Edvardsen O., Campagne F., Vriend G. GPCRDB: an information system for G protein-coupled receptors. Nucleic Acids Res. 26:1998;275-279.
116. Horn F., Vriend G., Cohen F.E. Collecting and harvesting biological data: the GPCRDB and NucleaRDB information systems. Nucleic Acids Res. 29:2001;346-349.
117. Hur E.M., Kim K.T. G protein-coupled receptor signalling and cross-talk: achieving rapidity and specificity. Cell Signal. 14:2002;397-405.
118. Iida-Klein A., Guo J., Xie L.Y., Juppner H., Potts J.T., Kronenberg H.M., Bringhurst F.R., Abou-Samra A.B., Segre G.V. Truncation of the carboxyl-terminal region of the rat parathyroid hormone (PTH)/PTH-related peptide receptor enhances PTH stimulation of adenylyl cyclase but not phospholipase C. J Biol Chem. 270:1995;8458-8465.
119. Iida-Klein A., Guo J., Takemura M., Drake M.T., Potts J.-T.J., Abou-Samra A., Bringhurst F.R., Segre G.V. Mutations in the second cytoplasmic loop of the rat parathyroid hormone (PTH)/PTH-related protein receptor result in selective loss of PTH-stimulated phospholipase C activity. J Biol Chem. 272:1997;6882-6889.
120. o coupling. Biochemistry. 39:2000;686-692.
121. Ingi T., Krumins A.M., Chidiac P., Brothers G.M., Chung S., Snow B.E., Barnes C.A., Lanahan A.A., Siderovski D.P., Ross E.M., Gilman A.G., Worley P.F. Dynamic regulation of RGS2 suggests a novel mechanism in G-protein signaling and neuronal plasticity. J Neurosci. 18:1998;7178-7188.
122. 1 dopamine receptors couple to multiple Gα proteins in different brain regions. J Neurochem. 78:2001;981-990.
123. Joly C., Gomeza J., Brabet I., Curry K., Bockaert J., Pin J.P. Molecular, functional, and pharmacological characterization of the metabotropic glutamate receptor type 5 splice variants: comparison with mGluR1. J Neurosci. 15:1995;3970-3981.
124. Jones S.B., Halenda S.P., Bylund D.B. Alpha 2-adrenergic receptor stimulation of phospholipase A2 and of adenylate cyclase in transfected Chinese hamster ovary cells is mediated by different mechanisms. Mol Pharmacol. 39:1991;239-245.
125. Jordan B.A., Devi L.A. G-protein-coupled receptor heterodimerization modulates receptor function. Nature. 399:1999;697-700.
126. 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. Proc Natl Acad Sci USA. 98:2001;343-348.
127. Karlin A. On the application of "a plausible model" of allosteric proteins to the receptor for acetylcholine. J Theor Biol. 16:1967;306-320.
128. i proteins. FEBS Lett. 355:1994;41-44.
129. Katz A., Wu D., Simon M.I. Subunits beta gamma of heterotrimeric G protein activate beta 2 isoform of phospholipase C. Nature. 360:1992;686-689.
130. Kenakin T. Agonist-receptor efficacy: I. Mechanisms of efficacy and receptor promiscuity. Trends Pharmacol Sci. 16:1995;188-192.
131. Kenakin T. Agonist-receptor efficacy: II. Agonist trafficking of receptor signals. Trends Pharmacol Sci. 16:1995;232-238.
132. Kenakin T. Inverse, protean, and ligand-selective agonism: matters of receptor conformation. FASEB J. 15:2001;598-611.
133. Kenakin T. Drug efficacy at G protein-coupled receptors. Annu Rev Pharmacol Toxicol. 42:2002;349-379.
134. i. Circ Res. 87:2000;705-709.
135. Kjelsberg M.A., Cotecchia S., Ostrowski J., Caron M.G., Lefkowitz R.J. Constitutive activation of the alpha 1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation. J Biol Chem. 267:1992;1430-1433.
136. Klein J., Reymann K.G., Riedel G. Activation of phospholipases C and D by the novel metabotropic glutamate receptor agonist tADA. Neuropharmacology. 36:1997;261-263.
137. Koller E., Gaarde W.A., Monia B.P. Elucidating cell signaling mechanisms using antisense technology. Trends Pharmacol Sci. 21:2000;142-148.
138. Kosugi S., Mori T. The intracellular region adjacent to plasma membrane (residues 684-692) of the thyrotropin receptor is important for phosphoinositide signaling but not for agonist-induced adenylate cyclase activation. Biochem Biophys Res Commun. 199:1994;1497-1503.
139. s complex: evidence for agonist-specific states. Mol Pharmacol. 52:1997;144-154.
140. Krupnick J.G., Benovic J.L. The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu Rev Pharmacol Toxicol. 38:1998;289-319.
141. i2. Biochemistry. 38:1999;12490-12498.
142. 2 histamine receptor to phospholipase C. Mol Endocrinol. 10:1996;1697-1707.
143. s-protein coupling and effector response. Trends Pharmacol Sci. 22:2001;616-622.
144. Laugwitz K.L., Allgeier A., Offermanns S., Spicher K., Van-Sande J., Dumont J.E., Schultz G. The human thyrotropin receptor: a heptahelical receptor capable of stimulating members of all four G protein families. Proc Natl Acad Sci USA. 93:1996;116-120.
145. 2-adrenergic receptor internalization and ERK signaling efficacy. J Biol Chem. 277:2002;35402-35410.
146. q-coupled effector signaling. J Biol Chem. 276:2001;33596-33607.
147. Leff P. The two-state model of receptor activation. Trends Pharmacol Sci. 16:1995;89-97.
148. Leff P., Scaramellini C. Promiscuity, pre-coupling and instability. Trends Pharmacol Sci. 19:1998;13.
149. Leff P., Scaramellini C., Law C., McKechnie K. A three-state receptor model of agonist action. Trends Pharmacol Sci. 18:1997;355-362.
150. Lefkowitz R.J. G protein-coupled receptors: III. New roles for receptor kinases and β-arrestins in receptor signaling and desensitization. J Biol Chem. 273:1998;18677-18680.
151. Lefkowitz R.J., Cotecchia S., Samama P., Costa T. Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol Sci. 14:1993;303-307.
152. Lefkowitz R.J., Pierce K.L., Luttrell L.M. Dancing with different partners: protein kinase a phosphorylation of seven membrane-spanning receptors regulates their G protein-coupling specificity. Mol Pharmacol. 62:2002;971-974.
153. Li X.M., Hedlund P.B., Fuxe K. Strong effects of NT/NN peptides on DA D2 receptors in rat neostriatal sections. NeuroReport. 5:1994;1621-1624.
154. 2A-adrenergic receptor is a protein kinase C-sensitive effector coupling switch. Biochemistry. 40:2001;15031-15037.
155. Lienhardt A., Garabédian M., Bai M., Sinding C., Zhang Z., Lagarde J.P., Boulesteix J., Rigaud M., Brown E.M., Kottler M.L. A large homozygous or heterozygous in-frame deletion within the calcium-sensing receptor's carboxylterminal cytoplasmic tail that causes autosomal dominant hypocalcemia. J Clin Endocrinol Metab. 85:2000;1695-1702.
156. s. Requirement for multiple cytoplasmic domains in the coupling process. J Biol Chem. 266:1991;4816-4821.
157. 2a receptors are labeled by agonists and discriminated by antagonists. Mol Pharmacol. 60:2001;690-699.
158. i in pancreatic and submandibular gland cells. J Biol Chem. 274:1999;17684-17690.
159. MacKinnon A.C., Waters C., Jodrell D., Haslett C., Sethi T. Bombesin and substance P analogues differentially regulate G-protein coupling to the bombesin receptor. Direct evidence for biased agonism. J Biol Chem. 276:2001;28083-28091.
160. + exchanger regulatory factor 2 directs parathyroid hormone 1 receptor signalling. Nature. 417:2002;858-861.
161. s in a ligand-dependent manner. J Neurochem. 75:2000;1283-1293.
162. Marchal-Victorion S., Vionnet N., Escrieut C., Dematos F., Dina C., Dufresne M., Vaysse N., Pradayrol L., Froguel P., Fourmy D. Genetic, pharmacological and functional analysis of cholecystokinin-1 and cholecystokinin-2 receptor polymorphism in type 2 diabetes and obese patients. Pharmacogenetics. 12:2002;23-30.
163. Mary S., Stephan D., Gomeza J., Bockaert J., Pruss R.M., Pin J.P. The rat mGlu1d receptor splice variant shares functional properties with the other short isoforms of mGlu1 receptor. Eur J Pharmacol. 335:1997;65-72.
164. 1-adrenergic receptor. J Biol Chem. 274:1999;12670-12674.
165. Mellado M., Rodriguez-Frade J.M., Vila-Coro A.J., Fernandez S., de Ana A.M., Jones D.R., Toran J.L., Martinez A. Chemokine receptor homo- or heterodimerization activates distinct signaling pathways. EMBO J. 20:2001;2497-2507.
166. Miggin S.M., Kinsella B.T. Investigation of the mechanisms of G protein: effector coupling by the human and mouse prostacyclin receptors. Identification of critical species-dependent differences. J Biol Chem. 277:2002;27053-27064.
167. Milligan G. The stoichiometry of expression of protein components of the stimulatory adenylyl cyclase cascade and the regulation of information transfer. Cell Signal. 8:1996;87-95.
168. Milligan G. Insights into ligand pharmacology using receptor-G-protein fusion proteins. Trends Pharmacol Sci. 21:2000;24-28.
169. Morris A.J., Malbon C.C. Physiological regulation of G protein-linked signaling. Physiol Rev. 79:1999;1373-1430.
170. Morris A.J., Scarlata S. Regulation of effectors by G-protein α- and βγ-subunits. Recent insights from studies of the phospholipase C-β isoenzymes. Biochem Pharmacol. 54:1997;429-435.
171. sα in NG108-15, neuroblastoma×glioma cells: effects on receptor regulation of the stimulatory adenylyl cyclase cascade. FEBS Lett. 397:1996;325-330.
172. Muller G. Towards 3D structures of G protein-coupled receptors: a multidisciplinary approach. Curr Med Chem. 7:2000;861-888.
173. Najimi M., Gailly P., Maloteaux J.M., Hermans E. Distinct regions of the high affinity neurotensin receptor mediate the functional coupling with PTx sensitive and insensitive G proteins. FEBS Lett. 512:2002;329-333.
174. Nakagawa T., Ozawa T., Shige K., Yamamoto R., Minami M., Satoh M. Inhibition of morphine tolerance and dependence by MS-153, a glutamate transporter activator. Eur J Pharmacol. 419:2001;39-45.
175. Namba T., Sugimoto Y., Negishi M., Irie A., Ushikubi F., Kakizuka A., Ito S., Ichikawa A., Narumiya S. Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity. Nature. 365:1993;166-170.
176. Nasman J., Kukkonen J.P., Ammoun S., Akerman K.E.O. Role of G-protein availability in differential signaling by alpha 2-adrenoceptors. Biochem Pharmacol. 62:2001;913-922.
177. o. J Biol Chem. 268:1993;26067-26070.
178. s through interaction of α-carboxylic acid of agonist and arginine residue of seventh transmembrane domain. J Biol Chem. 270:1995;16122-16127.
179. Nemeth K., Chollet A. A single mutation of the neurokinin-2 (NK2) receptor prevents agonist-induced desensitization. Divergent conformational requirements for NK2 receptor signaling and agonist-induced desensitization in Xenopus oocytes. J Biol Chem. 270:1995;27601-27605.
180. Neubig R.R. Membrane organization in G-protein mechanisms. FASEB J. 8:1994;939-946.
181. 35S]thio)-triphosphate binding and antibody study. Mol Pharmacol. 55:1999;564-574.
182. Nguyen Q.D., Faivre S., Bruyneel E., Rivat C., Seto M., Endo T., Mareel M., Emami S., Gespach C. RhoA- and RhoD-dependent regulatory switch of Gα subunit signaling by PAR-1 receptors in cellular invasion. FASEB J. 16:2002;565-576.
183. Nussenzveig D.R., Thaw C.N., Gershengorn M.C. Inhibition of inositol phosphate second messenger formation by intracellular loop one of a human calcitonin receptor. Expression and mutational analysis of synthetic receptor genes. J Biol Chem. 269:1994;28123-28129.
184. 341 in the carboxyl tail leads to an uncoupled nonpalmitoylated form of the receptor. J Biol Chem. 264:1989;7564-7569.
185. Offermanns S., Wieland T., Homann D., Sandmann J., Bombien E., Spicher K., Schultz G., Jakobs K.H. Transfected muscarinic acetylcholine receptors selectively couple to Gi-type G proteins and Gq/11. Mol Pharmacol. 45:1994;890-898.
186. q family members couple parathyroid hormone (PTH)/PTH-related peptide and calcitonin receptors to phospholipase C in COS-7 cells. Mol Endocrinol. 10:1996;566-574.
187. Ogino Y., Tanaka K., Shimizu N. Direct evidence for two distinct G proteins coupling with thrombin receptors in human neuroblastoma SH-EP cells. Eur J Pharmacol. 316:1996;105-109.
188. s target lipid rafts by default. Mol Biol Cell. 12:2001;685-698.
189. Okada T., Le Trong I., Fox B.A., Behnke C.A., Stenkamp R.E., Palczewski K. X-ray diffraction analysis of three-dimensional crystals of bovine rhodopsin obtained from mixed micelles. J Struct Biol. 130:2000;73-80.
190. Okamoto T., Murayama Y., Hayashi Y., Inagaki M., Ogata E., Nishimoto I. Identification of a Gs activator region of the β2-adrenergic receptor that is autoregulated via protein kinase A-dependent phosphorylation. Cell. 67:1991;723-730.
191. B. Its critical role in G protein coupling and a differential requirement for the cytoplasmic tail by G protein subtypes. J Biol Chem. 272:1997;21589-21596.
192. Okamoto Y., Ninomiya H., Tanioka M., Sakamoto A., Miwa S., Masaki T. Cysteine residues in the carboxyl terminal domain of the endothelin-B receptor are required for coupling with G-proteins. J Cardiovasc Pharmacol. 31(Suppl. 1):1998;S230-S232.
193. Oksche A., Rosenthal W. The molecular basis of nephrogenic diabetes insipidus. J Mol Med. 76:1998;326-337.
194. Ostrom R.S. New determinants of receptor-effector coupling: trafficking and compartmentation in membrane microdomains. Mol Pharmacol. 61:2002;473-476.
195. s. J Pharmacol Exp Ther. 294:2000;407-412.
196. Paasche J.D., Attramadal T., Sandberg C., Johansen H.K., Attramadal H. Mechanisms of endothelin receptor subtype-specific targeting to distinct intracellular trafficking pathways. J Biol Chem. 276:2001;34041-34050.
197. Palanche T., Ilien B., Zoffmann S., Reck M.P., Bucher B., Edelstein S.J., Galzi J.L. The neurokinin A receptor activates calcium and cAMP responses through distinct conformational states. J Biol Chem. 276:2001;34853-34861.
198. Palaparti A., Ge C., Anand-Srivastava M.B. Angiotensin II enhances the expression of Giα in A10 cells (smooth muscle): relationship with adenylyl cyclase activity. Arch Biochem Biophys. 365:1999;113-122.
199. 3 adenosine receptor. J Biol Chem. 270:1995;16895-16902.
200. 35S]GTPγS binding and phosphoinositide hydrolysis in rat and monkey brain. Neuropharmacology. 40:2001;826-837.
201. 2+ cascades. Mol Endocrinol. 9:1995;725-733.
202. αo protein coexpression: evidence for inverse agonism. J Pharmacol Exp Ther. 292:2000;654-663.
203. Perez D.M., Hwa J., Gaivin R., Mathur M., Brown F., Graham R.M. Constitutive activation of a single effector pathway: evidence for multiple activation states of a G protein-coupled receptor. Mol Pharmacol. 49:1996;112-122.
204. 4 receptor splice variants: compound specificity and dual coupling with Gαs- and Gαi/o-proteins. Mol Pharmacol. 61:2002;85-96.
205. B receptor is coupled to two effector pathways through pertussis toxin-sensitive and -insensitive G proteins. J Neurochem. 73:1999;281-288.
206. Pradier L., Menager J., Le-Guern J., Bock M.D., Heuillet E., Fardin V., Garret C., Doble A., Mayaux J.F. Septide: an agonist for the NK1 receptor acting at a site distinct from substance P. Mol Pharmacol. 45:1994;287-293.
207. 1-adrenergic receptor affect agonist-promoted trafficking. J Cardiovasc Pharmacol. 39:2002;155-160.
208. Reale V., Hannan F., Hall L.M., Evans P.D. Agonist-specific coupling of a cloned Drosophila melanogaster D1-like dopamine receptor to multiple second messenger pathways by synthetic agonists. J Neurosci. 17:1997;6545-6553.
209. Rhee S.G., Bae Y.S. Regulation of phosphoinositide-specific phospholipase C isozymes. J Biol Chem. 272:1997;15045-15048.
210. Rios C.D., Jordan B.A., Gomes I., Devi L.A. G-protein-coupled receptor dimerization: modulation of receptor function. Pharmacol Ther. 92:2001;71-87.
211. Robb S., Cheek T.R., Hannan F.L., Hall L.M., Midgley J.M., Evans P.D. Agonist-specific coupling of a cloned Drosophila octopamine/tyramine receptor to multiple second messenger systems. EMBO J. 13:1994;1325-1330.
212. Rodriguez-Moreno A., Sistiaga A., Lerma J., Sanchez-Prieto J. Switch from facilitation to inhibition of excitatory synaptic transmission by group I mGluR desensitization. Neuron. 21:1998;1477-1486.
213. Rubino T., Massi P., Patrini G., Vernier I., Giagnoni G., Parolaro D. Effect of chronic exposure to naltrexone and opioid selective agonists on G-protein messenger-RNA in the tay nervous system. Mol Brain Res. 23:1994;333-337.
214. 2-adrenoceptor subtypes. Br J Pharmacol. 131:2000;933-941.
215. Sagan S., Chassaing G., Pradier L., Lavielle S. Tachykinin peptides affect differently the second messenger pathways after binding to CHO-expressed human NK-1 receptors. J Pharmacol Exp Ther. 276:1996;1039-1048.
216. 2-adrenergic receptor. Extending the ternary complex model. J Biol Chem. 268:1993;4625-4636.
217. Sands S.A., Dickerson D.S., Morris S.J., Chronwall B.M. Dopamine D-2 receptor stimulation alters G-protein expression in rat pituitary intermediate lobe melanotropes. Endocrine. 6:1997;325-333.
218. 32P. J Cell Biochem. 73:1999;469-477.
219. Scaramellini C., Leff P. A three-state receptor model: predictions of multiple agonist pharmacology for the same receptor type. Ann N Y Acad Sci. 861:1998;97-103.
220. 2 to the nuclear envelope and endoplasmic reticulum. J Biol Chem. 270:1995;30749-30754.
221. Schipani E., Kruse K., Juppner H. A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science. 268:1995;98-100.
222. Schneider H., Feyen J.H., Seuwen K. A C-terminally truncated human parathyroid hormone receptor is functional and activates multiple G proteins. FEBS Lett. 351:1994;281-285.
223. s interactions: evidence for multiple receptor conformations. Mol Pharmacol. 56:1999;348-358.
224. Seifert R., Wenzel S.K., Kobilka B.K. GPCR-Gα fusion proteins: molecular analysis of receptor-G-protein coupling. Trends Pharmacol Sci. 20:1999;383-389.
225. Selkirk J.V., Price G.W., Nahorski S.R., Challiss R.A.J. Cell type-specific differences in the coupling of recombinant mGlu1α receptors to endogenous G protein sub-populations. Neuropharmacology. 40:2001;645-656.
226. Shi L.C., Wang H.Y., Horwitz J., Friedman E. Guanine nucleotide regulatory proteins, Gq and Gi1/2, mediate platelet-activating factor-stimulated phosphoinositide metabolism in immortalized hippocampal cells. J Neurochem. 67:1996;1478-1484.
227. 1 receptor. Biochem Biophys Res Commun. 272:2000;922-928.
228. Shyu J.F., Inoue D., Baron R., Horne W.C. The deletion of 14 amino acids in the seventh transmembrane domain of a naturally occurring calcitonin receptor isoform alters ligand binding and selectively abolishes coupling to phospholipase C. J Biol Chem. 271:1996;31127-31134.
229. Sidhu A., Sullivan M., Kohout T., Balen P., Fishman P. D1 dopamine receptors can interact with both stimulatory and inhibitory guanine nucleotide binding proteins. J Neurochem. 57:1991;1445-1451.
230. Song L., De Sarno P., Jope R.S. Muscarinic receptor stimulation increases regulators of G-protein signaling 2 mRNA levels through a protein kinase C-dependent mechanism. J Biol Chem. 274:1999;29689-29693.
231. Spengler D., Waeber C., Pantaloni C., Holsboer F., Bockaert J., Seeburg P.H., Journot L. Differential signal transduction by five splice variants of the PACAP receptor. Nature. 365:1993;170-175.
232. Stanasila L., Lim W.K., Neubig R.R., Pattus F. Coupling efficacy and selectivity of the human μ-opioid receptor expressed as receptor-Gα fusion proteins in Escherichia coli. J Neurochem. 75:2000;1190-1199.
233. Stanislaus D., Ponder S., Ji T.H., Conn P.M. Gonadotropin-releasing hormone receptor couples to multiple G proteins in rat gonadotrophs and in GGH3 cells: evidence from palmitoylation and overexpression of G proteins. Biol Reprod. 59:1998;579-586.
234. 2C receptor system: effector pathway and agonist dependence. J Pharmacol Exp Ther. 302:2002;957-962.
235. i proteins. J Biol Chem. 268:1993;2712-2718.
236. Sunahara R.K., Dessauer C.W., Gilman A.G. Complexity and diversity of mammalian adenylyl cyclases. Annu Rev Pharmacol Toxicol. 36:1996;461-480.
237. Takasu H., Gardella T.J., Luck M.D., Potts J.T., Bringhurst F.R. Amino-terminal modifications of human parathyroid hormone (PTH) selectively alter phospholipase C signaling via the type 1 PTH receptor: implications for design of signal-specific PTH ligands. Biochemistry. 38:1999;13453-13460.
238. Taussig R., Gilman A.G. Mammalian membrane-bound adenylyl cyclases. J Biol Chem. 270:1995;1-4.
239. Theroux T.L., Esbenshade T.A., Peavy R.D., Minneman K.P. Coupling efficiencies of human alpha 1-adrenergic receptor subtypes: titration of receptor density and responsiveness with inducible and repressible expression vectors. Mol Pharmacol. 50:1996;1376-1387.
240. Thron C.D. On the analysis of pharmacological experiments in terms of an allosteric receptor model. Mol Pharmacol. 9:1973;1-9.
241. Tobin A.B. Are we β-ARKing up the wrong tree? Casein kinase 1α provides an additional pathway for GPCR phosphorylation. Trends Pharmacol Sci. 23:2002;337-343.
242. 1 cells. J Biol Chem. 265:1990;10320-10326.
243. Vanderbeld B., Kelly G.M. New thoughts on the role of the betagamma subunit in G protein signal transduction. Biochem Cell Biol. 78:2000;537-550.
244. Vanetti M., Vogt G., Hollt V. The two isoforms of the mouse somatostatin receptor (mSSTR2A and mSSTR2B) differ in coupling efficiency to adenylate cyclase and in agonist-induced receptor desensitization. FEBS Lett. 331:1993;260-266.
245. 2 cascades in CHO cells expressing the human cDNA of TSH receptor. Mol Cell Endocrinol. 74:1990;R1-R6.
246. s activation. Mol Pharmacol. 56:1999;1005-1013.
247. Wang H.Y., Undie A.S., Friedman E. Evidence for the coupling of Gq protein to D1-like dopamine sites in rat striatum: possible role in dopamine-mediated inositol phosphate formation. Mol Pharmacol. 48:1995;988-994.
248. 2 receptor activates adenylate cyclase and PLC via separate GTP-dependent pathways. Am J Physiol Gastrointest Liver Physiol. 34:1996;G613-G620.
249. Wang D.X., Quillan J.M., Winans K., Lucas J.L., Sadee W. Single nucleotide polymorphisms in the human μ opioid receptor gene alter basal G protein coupling and calmodulin binding. J Biol Chem. 276:2001;34624-34630.
250. Watson C., Chen G., Irving P., Way J., Chen W.J., Kenakin T. The use of stimulus-biased assay systems to detect agonist-specific receptor active states: implications for the trafficking of receptor stimulus by agonists. Mol Pharmacol. 58:2000;1230-1238.
251. q-proteins. Mol Pharmacol. 58:2000;954-966.
252. Wess J. G-protein-coupled receptors: molecular mechanisms involved in receptor activation and selectivity of G-protein recognition. FASEB J. 11:1997;346-354.
253. Wess J. Molecular basis of receptor/G-protein-coupling selectivity. Pharmacol Ther. 80:1998;231-264.
254. Wieland T., Chen C.K. Regulators of G-protein signalling: a novel protein family involved in timely deactivation and desensitization of signalling via heterotrimeric G proteins. Naunyn-Schmiedeberg's Arch Pharmacol. 360:1999;14-26.
255. 2S dopamine receptor: evidence for multiple, agonist-specific active conformations. Mol Pharmacol. 54:1998;435-444.
256. 12 families of heterotrimeric G proteins. J Biol Chem. 274:1999;27351-27358.
257. i/oα fusion proteins. Biochemistry. 38:1999;2272-2278.
258. 12 proteins. Oncogene. 19:2000;4199-4209.
259. Wolsing D.H., Rosenbaum J.S. The mechanism for the rapid desensitization in bradykinin-stimulated inositol monophosphate production in NG108-15 cells involves interaction of a single receptor with multiple signaling pathways. J Pharmacol Exp Ther. 266:1993;253-261.
260. Wu V., Yang M., McRoberts J.A., Ren J., Seensalu R., Zeng N., Dagrag M., Birnbaumer M., Walsh J.H. First intracellular loop of the human cholecystokinin-A receptor is essential for cyclic AMP signaling in transfected HEK-293 cells. J Biol Chem. 272:1997;9037-9042.
261. 1 adrenergic receptor modulates receptor trafficking and signaling in cardiac myocytes. J Biol Chem. 277:2002;33783-33790.
262. i proteins. Sci STKE. 2001:2001;RE15.
263. q-coupled receptors. J Biol Chem. 274:1999;3549-3556.
264. q-mediated activation of mitogen-activated protein kinase and phosphoinositide synthesis. J Biol Chem. 272:1997;11924-11927.
265. i. Demonstration in a reconstituted system. J Biol Chem. 277:2002;31249-31256.
266. o subtype of G proteins in SH-SY5Y cells. Br J Pharmacol. 128:1999;1181-1188.
267. 3 muscarinic acetylcholine receptor is essential for proper receptor cell surface localization but not for G protein coupling. J Neurochem. 72:1999;2404-2414.
268. Zgombick J.M., Borden L.A., Cochran T.L., Kucharewicz S.A., Weinshank R.L., Branchek T.A. Dual coupling of cloned human 5-hydroxytryptamine1D alpha and 5-hydroxytryptamine1D beta receptors stably expressed in murine fibroblasts: inhibition of adenylate cyclase and elevation of intracellular calcium concentrations via pertussis toxin-sensitive G protein(s). Mol Pharmacol. 44:1993;575-582.
269. s and sorting nexin in vesicular trafficking. Science. 294:2002;1939-1942.
270. Zhu X., Gilbert S., Birnbaumer M., Birnbaumer L. Dual signaling potential is common among Gs-coupled receptors and dependent on receptor density. Mol Pharmacol. 56:1994;460-469.